Drug application
SODIUM FLUORIDE F 18 (SODIUM FLUORIDE F-18)
Drugs@FDA NDA 022494 · NIH NCI DCTD
Key facts
| Drug name | SODIUM FLUORIDE F 18 |
|---|---|
| Active ingredients | SODIUM FLUORIDE F-18 |
| Application type | NDA |
| Application number | 022494 |
| Company | NIH NCI DCTD |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | 10-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Jan 26, 2011 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: